The temporomandibular joint (TMJ) is an intricate structure composed of the mandibular condyle, articular disc, and glenoid fossa in the temporal bone. Apical condylar cartilage is classified as a secondary cartilage, is fibrocartilaginous in nature, and is structurally distinct from growth plate and articular cartilage in long bones. Condylar cartilage is organized in distinct cellular layers that include a superficial layer that produces lubricants, a polymorphic/progenitor layer that contains stem/progenitor cells, and underlying layers of flattened and hypertrophic chondrocytes. Uniquely, progenitor cells reside near the articular surface, proliferate, undergo chondrogenesis, and mature into hypertrophic chondrocytes. During the past decades, there has been a growing interest in the molecular mechanisms by which the TMJ develops and acquires its unique structural and functional features. Indian hedgehog (Ihh), which regulates skeletal development including synovial joint formation, also plays pivotal roles in TMJ development and postnatal maintenance. This review provides a description of the many important recent advances in Hedgehog (Hh) signaling in TMJ biology. These include studies that used conventional approaches and those that analyzed the phenotype of tissue-specific mouse mutants lacking Ihh or associated molecules. The recent advances in understanding the molecular mechanism regulating TMJ development are impressive and these findings will have major implications for future translational medicine tools to repair and regenerate TMJ congenital anomalies and acquired diseases, such as degenerative damage in TMJ osteoarthritic conditions.
The process of fracture healing consists of an inflammatory reaction and cartilage and bone tissue reconstruction. The inflammatory cytokine interleukin-1β (IL-1β) signal is an important major factor in fracture healing, whereas its relevance to retinoid receptor (an RAR inverse agonist, which promotes endochondral bone formation) remains unclear. Herein, we investigated the expressions of IL-1β and retinoic acid receptor gamma (RARγ) in a rat fracture model and the effects of IL-1β in the presence of one of several RAR inverse agonists on chondrocytes. An immunohistochemical analysis revealed that IL-1β and RARγ were expressed in chondrocytes at the fracture site in the rat ribs on day 7 post-fracture. In chondrogenic ATDC5 cells, IL-1β decreases the levels of aggrecan and type II collagen but significantly increased the metalloproteinase-13 (Mmp13) mRNA by real-time reverse transcription-polymerase chain reaction (RT-PCR) analysis. An RAR inverse agonist (AGN194310) inhibited IL-1β-stimulated Mmp13 and Ccn2 mRNA in a dose-dependent manner. Phosphorylated extracellular signal regulated-kinases (pERK1/2) and p-p38 mitogen-activated protein kinase (MAPK) were increased time-dependently by IL-1β treatment, and the IL-1β-induced p-p38 MAPK was inhibited by AGN194310. Experimental p38 inhibition led to a drop in the IL-1β-stimulated expressions of Mmp13 and Ccn2 mRNA. MMP13, CCN2, and p-p38 MAPK were expressed in hypertrophic chondrocytes near the invaded vascular endothelial cells. As a whole, these results point to role of the IL-1β via p38 MAPK as important signaling in the regulation of the endochondral bone formation in fracture healing, and to the actions of RAR inverse agonists as potentially relevant modulators of this process.
10 September 2024 in Journal of Oral and Maxillofacial Surgery, Medicine, and Pathology
Carbonate apatite (CO3Ap) granules have been employed as advanced bone substitutes owing to their capacity to remodel into new natural bone, aligning with the bone remodeling process. Their application spans dental clinical fields in both Japan and the US. Nonetheless, owing to the granular nature of CO3Ap, certain challenges in the application of these materials can arise, such as intraoperative scattering and postoperative migration. To address these issues, we integrated CO3Ap granules with collagen to generate a sponge-like composite. Collagen, typically derived from bovine or porcine sources, is commonly utilized in clinical settings despite the potential for infections, including parasitic zoonosis. For the purposes of this study, we selected fish-derived collagen (FC), which minimizes the risk of zoonotic complications. Compared with CO3Ap-G, the CO3Ap granule/FC composites (CO3Ap-G/FCs) fabricated in this study were characterized by an enhanced handling performance. Bone regeneration ability was assessed by implanting these composites into critical-size defects in rat calvarial bones for 2–4 weeks using CO3Ap-G and FC as controls. Radiographic and histological examinations revealed that the bone-regenerative capacity of CO3Ap-G/FCs was equivalent to that of CO3Ap-G. We accordingly conclude that sponge-like CO3Ap-G/FC composites have potential utility as ideal bone substitutes, in that they can be manipulated with forceps, bent, and cut with scissors, without losing the bone-regenerative properties of CO3Ap-G. Graphical Abstract
(1) Background: OK-432 is a penicillin-killed, lyophilized formulation of a low-toxicity strain (Su) of Streptococcus pyogenes (Group A). It is a potent immunotherapy agent for several types of cancer, including oral cancer. We previously showed that (i) OK-432 treatment induces a high amount of IFN-γ production from peripheral blood mononuclear cells (PBMCs), and (ii) conditioned medium (CM) from oral cancer cells suppresses both the IFN-γ production and cytotoxic activity of PBMCs driven by OK-432. The aim of this study was to determine the inhibitory mechanism of OK-432-induced IFN-γ production from PBMCs by CM. (2) Methods: We performed cDNA microarray analysis, quantitative RT-PCR, and ELISA to reveal the inhibitory mechanism of CM. (3) Results: We found that CD40 plays a key role in IFN-γ production via IL-12 production. Although OK-432 treatment upregulated the expression levels of the IL-12p40, p35, and CD40 genes, CM from oral cancer cells downregulate these genes. The amount of IFN-γ production by OK-432 treatment was decreased by an anti-CD40 neutralizing antibody. (4) Conclusions: Our study suggests that uncertain soluble factor(s) produced from oral cancer cells may inhibit IFN-γ production from PBMCs via suppressing the CD40/CD40L–IL-12 axis.
Ameloblastoma typically lacks a well‐defined capsule and exhibits locally invasive growth, making them prone to recurrence. On the other hand, a subtype known as the unicystic type is generally well circumscribed and less invasive compared with conventional solid/multicystic variants, but recurrence may occur in rare cases. Therefore, after tumor removal, it is essential to resect or curette the adjacent bone surface that may have been infiltrated. The high perimandibular approach is a surgical technique originally developed for treating condylar fractures. It involves a 4–5 cm skin incision placed 5 mm below the lower border of the mandible, followed by incision of the platysma and masseter muscles above the course of the mandibular branch of the facial nerve, thereby protecting the nerve. Compared with other surgical approaches, this method provides a wide operative field and superior esthetic outcomes, as postoperative scars are less conspicuous. In this report, we describe a case in which this approach was adapted for resecting a recurrent ameloblastoma of the mandibular ramus. The patient was a 58‐year‐old man who presented to our department in May 2016 with a lesion extending from the right mandibular body to the mandibular ramus. A diagnosis of ameloblastoma unicystic type was established, and fenestration procedures were performed in May 2017. However, further treatment was discontinued at the patient’s request. The tumor subsequently recurred on the lateral surface of the right mandibular ramus, measuring 28 mm × 14 mm. In May 2022, the lesion was resected using the extended high perimandibular approach: an extended incision of 10 cm, twice the usual length, provided sufficient surgical exposure to allow for safe and effective complete tumor removal. Postoperatively, no facial nerve paralysis occurred, and no recurrence was observed during 3 years of follow‐up. Esthetic outcomes were satisfactory. In conclusion, the extended high perimandibular approach may be a useful surgical option for managing recurrent ameloblastoma on the lateral surface of the mandibular ramus.